Last 12 quarters of trend data · Healthcare · Drug Distributors & Pharmacies
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -0.12 | 0.30 | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | 0.69 | 1.18 | 1.12 | 1.62 | 4.24 | 5.48 | 1.92 | 5.16 | — | — | — | — | — |
| — | -78.5% | -41.6% | -68.7% | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | — | 73.14 | — | — | — | 9.74 | 66.07 | 50.06 | — | — | — | — | — |
| — | +651.0% | — | — | — | — | — | — | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | -41.3% | 2.8% | -9.8% | 10.9% | -614.4% | 7.7% | 6.5% | 6.4% | 4.8% | 0.9% | 13.4% | 10.3% | 8.1% |
| — | -63.1% | -250.9% | +71.2% | -12777.5% | +708.3% | -51.6% | -38.3% | -39.9% | — | — | — | — | |
| Operating Margin | -347.9% | -126.4% | -412.7% | -385.7% | -766.0% | -1047.1% | -70.6% | -288.6% | -30.2% | -30.8% | -21.9% | -18.7% | -30.0% |
| — | +87.9% | -484.5% | -33.7% | -2436.8% | -3305.0% | -222.5% | -1442.7% | -0.6% | — | — | — | — | |
| Net Margin | -433.9% | 396.8% | -1031.7% | -496.5% | -1667.2% | -1139.0% | -85.6% | -298.5% | -34.9% | -32.9% | -22.8% | -22.4% | -34.3% |
| — | +134.8% | -1104.7% | -66.3% | -4676.5% | -3361.5% | -275.1% | -1235.5% | -1.7% | — | — | — | — |
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | — | 6167.8% | — | — | — | -893.3% | -247.9% | -578.4% | -51.8% | -41.4% | — | — | — |
| — | +790.4% | — | — | — | -2057.4% | — | — | — | — | — | — | — | |
| ROA | -230.7% | 29.6% | -58.4% | -25.6% | -66.9% | -64.1% | -11.9% | -56.2% | -7.7% | -3.7% | -6.0% | -5.1% | -3486.5% |
| — | +146.2% | -391.4% | +54.5% | -772.2% | -1621.7% | -97.8% | -998.4% | +99.8% | — | — | — | — | |
| ROIC | -282.6% | -16.7% | -45.0% | -34.6% | -46.8% | -87.5% | -15.6% | -80.4% | -9.1% | -5.1% | -9.1% | — | — |
| — | +80.9% | -189.6% | +56.9% | -416.8% | -1620.5% | -71.2% | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | 116.15 | — | — | — | 3.87 | 27.47 | 5.75 | 3.73 | 2.21 | — | — | — |
| — | +2905.0% | — | — | — | +74.8% | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 0.09 | 0.14 | 0.14 | 0.09 | 0.09 | 0.39 | 0.32 | 0.36 | 0.40 | 0.44 | 0.60 | 0.72 | 0.12 |
| — | -64.8% | -55.1% | -76.0% | -76.3% | -10.9% | -46.6% | -50.4% | +240.4% | — | — | — | — | |
| Quick Ratio | 0.04 | 0.10 | 0.10 | 0.03 | 0.04 | 0.16 | 0.11 | 0.15 | 0.15 | 0.14 | 0.23 | 0.26 | 0.12 |
| — | -38.7% | -1.0% | -77.9% | -73.3% | +14.3% | -54.3% | -42.5% | +26.8% | — | — | — | — | |
| Interest Coverage | -21.11 | -1.50 | -4.70 | -2.74 | -14.64 | -23.08 | -4.64 | -28.63 | -5.44 | -12.68 | -3.60 | -4.93 | -6.47 |
| — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 12 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying MEDS stock.
DataMEDS AI, Inc.'s current P/E is -0.1x. The average P/E over the last 1 quarters is 0.3x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
DataMEDS AI, Inc.'s current operating margin is -347.9%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking DataMEDS AI, Inc.'s business trajectory between earnings reports.